• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

getITD for FLT3-ITD-based MRD monitoring in AML.

作者信息

Blätte Tamara J, Schmalbrock Laura K, Skambraks Sabrina, Lux Susanne, Cocciardi Sibylle, Dolnik Anna, Döhner Hartmut, Döhner Konstanze, Bullinger Lars

机构信息

Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.

Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Berlin, Germany.

出版信息

Leukemia. 2019 Oct;33(10):2535-2539. doi: 10.1038/s41375-019-0483-z. Epub 2019 May 14.

DOI:10.1038/s41375-019-0483-z
PMID:31089248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8075860/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7971/8075860/5b07fd94bf2f/41375_2019_483_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7971/8075860/0aa4e5aa825a/41375_2019_483_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7971/8075860/5b07fd94bf2f/41375_2019_483_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7971/8075860/0aa4e5aa825a/41375_2019_483_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7971/8075860/5b07fd94bf2f/41375_2019_483_Fig2_HTML.jpg

相似文献

1
getITD for FLT3-ITD-based MRD monitoring in AML.获取用于急性髓系白血病中基于FLT3-ITD的微小残留病监测的ITD。
Leukemia. 2019 Oct;33(10):2535-2539. doi: 10.1038/s41375-019-0483-z. Epub 2019 May 14.
2
The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.无 FLT3-ITD、NPM1 和双等位 CEBPA 突变的中危急性髓系白血病微小残留病检测对预后和缓解后治疗选择的影响。
Hematology. 2021 Dec;26(1):179-185. doi: 10.1080/16078454.2021.1880753.
3
Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation.FLT3-ITD/CEBPA 基因突变和细胞遗传学正常的急性髓细胞白血病造血干细胞移植后微小残留病的临床意义。
J Cancer Res Clin Oncol. 2021 Sep;147(9):2659-2670. doi: 10.1007/s00432-021-03530-9. Epub 2021 Feb 7.
4
Improved FLT3 internal tandem duplication PCR assay predicts outcome after allogeneic transplant for acute myeloid leukemia.改良的FLT3内部串联重复PCR检测可预测急性髓系白血病异基因移植后的预后。
Biol Blood Marrow Transplant. 2014 Dec;20(12):1989-95. doi: 10.1016/j.bbmt.2014.08.015. Epub 2014 Aug 23.
5
Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients.通过超深度测序分析揭示非常小的FLT3内部串联重复突变克隆对急性髓系白血病患者具有重要的临床意义。
Oncotarget. 2015 Oct 13;6(31):31284-94. doi: 10.18632/oncotarget.5161.
6
Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples.配对的初发和复发急性髓系白血病样本中FLT3突变的稳定性及预后影响
Leukemia. 2006 Jul;20(7):1217-20. doi: 10.1038/sj.leu.2404246. Epub 2006 Apr 27.
7
Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.基于 FLT3 内部串联重复的成人急性髓细胞白血病微小残留病监测。
Leuk Res. 2012 Mar;36(3):316-23. doi: 10.1016/j.leukres.2011.11.002. Epub 2011 Nov 29.
8
Prognostic Value of -Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia.急性髓系白血病中-串联重复残留病的预后价值。
J Clin Oncol. 2023 Feb 1;41(4):756-765. doi: 10.1200/JCO.22.00715. Epub 2022 Oct 31.
9
Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group.FLT3-ITD 急性髓系白血病患儿的特征：来自 AIEOP AML-2002 研究组的报告。
Leukemia. 2017 Jan;31(1):18-25. doi: 10.1038/leu.2016.177. Epub 2016 Jun 28.
10
Patient-specific analysis of FLT3 internal tandem duplications for the prognostication and monitoring of acute myeloid leukemia.对 FLT3 内部串联重复进行个体化分析，用于急性髓系白血病的预后和监测。
Eur J Haematol. 2012 Jul;89(1):53-62. doi: 10.1111/j.1600-0609.2012.01785.x. Epub 2012 May 9.

引用本文的文献

1
An innovative full-size pathogenic tandem duplication mutation precise detection system based on next-generation sequencing.一种基于下一代测序的创新型全尺寸致病性串联重复突变精确检测系统。
Exp Biol Med (Maywood). 2025 Jul 11;250:10128. doi: 10.3389/ebm.2025.10128. eCollection 2025.
2
Allogeneic transplantation provides added benefit to FMS-like tyrosine kinase 3 (FLT3) inhibitors for both low-intensity and high-intensity regimens in FLT3-mutated acute myeloid leukemia.对于FLT3突变的急性髓系白血病，无论是低强度还是高强度方案，异基因移植都能为FMS样酪氨酸激酶3（FLT3）抑制剂带来额外益处。
Cancer. 2025 Jul 15;131(14):e35973. doi: 10.1002/cncr.35973.
3

本文引用的文献

1
Bim regulates the survival and suppressive capability of CD8 FOXP3 regulatory T cells during murine GVHD.Bim 调控小鼠移植物抗宿主病中 CD8 FOXP3 调节性 T 细胞的存活和抑制能力。
Blood. 2018 Jul 26;132(4):435-447. doi: 10.1182/blood-2017-09-807156. Epub 2018 May 16.
2
A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with -ITD mutations.基于下一代测序的 AML 患者伴-ITD 突变微小残留病灶评估检测方法。
Blood Adv. 2018 Apr 24;2(8):825-831. doi: 10.1182/bloodadvances.2018015925.
3
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
From prognostication to precision in acute myeloid leukemia.
从急性髓系白血病的预后判断到精准治疗
Blood. 2025 May 8;145(19):2105-2106. doi: 10.1182/blood.2024028105.
4
Cell-free DNA for detection and monitoring of extramedullary AML relapse.用于检测和监测髓外急性髓系白血病复发的游离DNA
Hemasphere. 2025 Mar 10;9(3):e70097. doi: 10.1002/hem3.70097. eCollection 2025 Mar.
5
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML.FLT3-ITD突变型急性髓系白血病患者的可测量残留病与移植后吉瑞替尼维持治疗
Blood. 2025 May 8;145(19):2138-2148. doi: 10.1182/blood.2024025154.
6
Quantification of the FLT3 internal tandem duplication is a reliable marker for monitoring measurable residual disease in acute myeloid leukemia with FLT3-ITD mutations.FLT3内部串联重复的定量分析是监测伴有FLT3-ITD突变的急性髓系白血病中可测量残留病的可靠标志物。
Bone Marrow Transplant. 2025 Mar;60(3):412-414. doi: 10.1038/s41409-024-02495-w. Epub 2024 Dec 10.
7
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin.在接受强化化疗加米哚妥林治疗的伴有FLT3-ITD的急性髓系白血病中进行可测量残留病监测。
Blood Adv. 2024 Dec 10;8(23):6067-6080. doi: 10.1182/bloodadvances.2024013758.
8
Measurable residual disease monitoring in AML: Prospects for therapeutic decision-making and new drug development.急性髓系白血病中可测量残留病监测：治疗决策与新药研发的前景
Am J Hematol. 2025 Mar;100 Suppl 2(Suppl 2):5-15. doi: 10.1002/ajh.27482. Epub 2024 Sep 25.
9
FLT3-TKD Measurable Residual Disease Detection Using Droplet Digital PCR and Clinical Applications in Acute Myeloid Leukemia.采用液滴数字 PCR 技术检测 FLT3-TKD 微小残留病灶及其在急性髓系白血病中的临床应用。
Int J Mol Sci. 2024 May 26;25(11):5771. doi: 10.3390/ijms25115771.
10
Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction.揭示 FLT3-ITD AML 的信号转导网络可提高药物敏感性预测。
Elife. 2024 Apr 2;12:RP90532. doi: 10.7554/eLife.90532.
急性髓系白血病中的微小残留病：来自欧洲白血病网微小残留病工作组的共识文件。
Blood. 2018 Mar 22;131(12):1275-1291. doi: 10.1182/blood-2017-09-801498. Epub 2018 Jan 12.
4
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.米哚妥林联合化疗治疗伴有FLT3突变的急性髓系白血病
N Engl J Med. 2017 Aug 3;377(5):454-464. doi: 10.1056/NEJMoa1614359. Epub 2017 Jun 23.
5
MRD in AML: does it already guide therapy decision-making?急性髓系白血病中的微小残留病：它已经能指导治疗决策了吗？
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):356-365. doi: 10.1182/asheducation-2016.1.356.
6
Acute Myeloid Leukemia.急性髓系白血病
N Engl J Med. 2015 Sep 17;373(12):1136-52. doi: 10.1056/NEJMra1406184.
7
Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemia.用于急性髓系白血病微小残留病监测的FLT3内部串联重复序列的下一代测序
Oncotarget. 2015 Sep 8;6(26):22812-21. doi: 10.18632/oncotarget.4333.
8
Differential impact of allelic ratio and insertion site in FLT3-ITD-positive AML with respect to allogeneic transplantation.FLT3-ITD 阳性 AML 中等位基因比和插入部位对异基因移植的影响差异。
Blood. 2014 Nov 27;124(23):3441-9. doi: 10.1182/blood-2014-05-578070. Epub 2014 Sep 30.
9
Detection of FLT3 internal tandem duplication in targeted, short-read-length, next-generation sequencing data.靶向、短读长、下一代测序数据中 FLT3 内部串联重复的检测。
J Mol Diagn. 2013 Jan;15(1):81-93. doi: 10.1016/j.jmoldx.2012.08.001. Epub 2012 Nov 14.
10
Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations.用于监测伴有 FLT3-ITD 或 NPM1 突变的急性髓系白血病患者微小残留病的下一代测序。
Genes Chromosomes Cancer. 2012 Jul;51(7):689-95. doi: 10.1002/gcc.21955. Epub 2012 Mar 27.